Skip to content

Income Tax at other companies

ALN
Alnylam PharmaceuticalsALNY
$15.66M-1.4%
Septerna, Inc. logo
Septerna, Inc.SEPN
$337K
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$621K-31.1%
Opko Health logo
Opko HealthOPK
-$6.11M-5.9%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$80K-191%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$3M+4,520%

Segments

By geography

See full
AU$1.19M

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossTax.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's income tax?
Tectonic Therapeutics (TECX) reported income tax of $25.2M in Q1 2026.
How has Tectonic Therapeutics's income tax changed year-over-year?
Tectonic Therapeutics's income tax increased by 58.4% year-over-year, from $15.91M to $25.2M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.